Navigation Links
GenVec Reports Fourth Quarter and 2010 Year-End Financial Results
Date:3/10/2011

le prior year period.  The Company reported revenues of $5.2 million in the fourth quarter of 2010 compared to $3.4 million for the same period in 2009.  This increase was primarily due to our collaboration with Novartis that began in 2010, we reported revenues of $3.2 million in the fourth quarter of 2010 with no revenue reported for this collaboration in the comparable period in 2009.  This increase was partially offset by a decrease in revenue associated with our HIV vaccine development program. Research and development expenses decreased 11% in 2010 from $5.5 million in the fourth quarter of 2009 to $4.9 million in the fourth quarter of 2010 due mainly to reduced personnel costs and costs related to the development of TNFerade, partially offset by increased manufacturing and development costs related to our hearing program. General and administrative expenses in the fourth quarter of 2010 decreased 26% to $1.5 million from $2.1 million in the comparable period in 2009 primarily due to reduced personnel costs and depreciation costs, partially offset by higher professional costs.

2011 GuidanceGenVec's Senior Vice President and Chief Financial Officer, Douglas J. Swirsky, commented, "For 2011, we anticipate our cash burn will be between $5.0 million and $7.0 million. In 2011, we foresee revenues from grants and collaborations totaling between $23.0 million and $25.0 million."

Conference Call Information GenVec will hold a conference call at 10:00 a.m. EST on Friday, March 11, 2011 to discuss the Company's financial results and 2011 business outlook. To listen to the live conference call, please dial 877-558-0567 (U.S. or Canada) or 706-643-4980 (international) and use the following Conference ID: 47418441. An audio replay of the conference call will be available starting at 1:00 p.m. EST on March 11, 2011 through March 17, 2011. To listen to the audio replay, dial 800-642-1687 or 706-645-9291 (international) and use access code 4
'/>"/>

SOURCE GenVec, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. GenVec Forms Collaboration With World-Leading Animal Health Company
2. GenVec Reports Third Quarter 2010 Financial Results
3. GenVec Receives Second-Year Funding From SAIC for HIV and Influenza Vaccine Development
4. GenVec Receives National Cancer Institute Grant to Expand Cancer Program
5. GenVec Announces Multiple Presentations at the American Society of Tropical Medicine and Hygiene Meeting
6. Transgenomic Reports Fourth Quarter Financial Results
7. Orexigen® Therapeutics Reports Fourth Quarter and Year Ended December 31, 2010 Financial Results
8. Six-Month Prospective Multi-Center Study Reports Efficacy Rates for AMS Elevate Anterior and Apical Prolapse Repair System
9. Sinovac Reports Positive Preliminary Phase I Clinical Trial Results for EV71 Vaccine in Adult Group
10. Cardiogenesis Reports Fourth Quarter and Full Year 2010 Results
11. Cellceutix Reports Confidential Disclosure Agreement Signed With Major Pharmaceutical Company
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2014)...  Northstar Global Business Services, Inc. (OTCPink:MDIN) today ... made their final decision and has determined to ... effective December 15, 2014, and has resumed accepting ... book entry transfer services. All deposit restrictions have been ... fully "DTC Eligible", and has resumed electronic trading ...
(Date:12/17/2014)... 2014  Beamz Interactive, Inc. (OTCQB: BZIC), a ... announced that it has signed an agreement with ... of innovative prosthetic, orthotic and assistive technology products ... agreement, RSL Steeper will promote and supply the ... use within UK residential care facilities through its ...
(Date:12/17/2014)... 17, 2014  ImmunoCellular Therapeutics, Ltd. ("ImmunoCellular") (NYSE ... Trademark Office (USPTO) has issued a key patent ... immunotherapeutic vaccine targeting six tumor antigens that are ... Patent No. 8,871,211, which issued October 28, 2014, ... a dendritic cell composition comprising peptide epitopes of ...
Breaking Medicine Technology:Northstar announces that the DTC chill on MDIN has been officially lifted 2Northstar announces that the DTC chill on MDIN has been officially lifted 3Beamz Interactive, Inc. Signs UK Distribution Agreement with RSL Steeper Limited 2Beamz Interactive, Inc. Signs UK Distribution Agreement with RSL Steeper Limited 3ImmunoCellular Therapeutics Announces Issuance of Key Patent For ICT-107 Cancer Vaccine 2
... Consulting, a business unit of PAREXEL International (Nasdaq: ... serving the biopharmaceutical and medical device industries, today released ... provide key insights into emerging areas of biosimilar development. ... Consultant and Cecil Nick, B.Sc. (Hons), Vice President, Biotechnology, ...
... of Primary Astrocytes With Anti-GLAST MicroBeads -- BERGISCH GLADBACH, Germany, September 22, 2010 ... ... --> ... s = ,; var first_result; // Results are keyed by longUrl, so we need to grab the ...
Cached Medicine Technology:PAREXEL Consulting Thought Leaders Provide Insights Into U.S. Biosimilar Development and Monoclonal Biosimilars in Two New White Papers 2PAREXEL Consulting Thought Leaders Provide Insights Into U.S. Biosimilar Development and Monoclonal Biosimilars in Two New White Papers 3PAREXEL Consulting Thought Leaders Provide Insights Into U.S. Biosimilar Development and Monoclonal Biosimilars in Two New White Papers 4PAREXEL Consulting Thought Leaders Provide Insights Into U.S. Biosimilar Development and Monoclonal Biosimilars in Two New White Papers 5Direct Isolation of Primary Astrocytes With Anti-GLAST MicroBeads 2Direct Isolation of Primary Astrocytes With Anti-GLAST MicroBeads 3Direct Isolation of Primary Astrocytes With Anti-GLAST MicroBeads 4Direct Isolation of Primary Astrocytes With Anti-GLAST MicroBeads 5Direct Isolation of Primary Astrocytes With Anti-GLAST MicroBeads 6
(Date:12/21/2014)... Over the past 39 years, NES Health ... emergency departments across the nation, from quality of medical ... into an innovative suite of tools, systems, and programs ... the patient experience. , NES Health, a leading ... services for hospitals, announced the development and launch of ...
(Date:12/21/2014)... Theme and plugin developers from ... for Final Cut Pro X entitled ProMotion. , “ProMotion ... with absolute ease.” Said Christiana Austin, CEO of Pixel ... to easily animate their media inside FCPX.” , Pixel ... to animate pictures, videos, logos, and more with absolute ...
(Date:12/21/2014)... 21, 2014 CannabisClassifieds.com celebrates marijuana’s new legal ... only one of its kind, the site has provided its ... for 14 years running. It uniquely combines the benefits ... cannabis readily available to the masses. Assuring the potent ... golden ring of public approval. , Shane Chattin, ...
(Date:12/21/2014)... December 21, 2014 Concept Plus, LLC. ... firm headquartered in Fairfax, VA., today announced it has ... Fast 50 list, which ranks the fastest growing government contracting ... 2009 to 2013. , This is the first year that ... ranked # 20 with a 95.92% compound annual growth rate. ...
(Date:12/20/2014)... 21, 2014 BambooIndustry.com is ... the business has announced its bamboo flooring promotion ... best material from certified suppliers, and offers the ... worldwide. In the current promotion, all customers can ... when they say they know BambooIndustry.com from press ...
Breaking Medicine News(10 mins):Health News:NES Health Launches Stipend Program for Emergency Physicians in Training to Financially Assist Emergency Department Doctors While They Learn 2Health News:Announcing a new plugin for Final Cut Pro X ProMotion from Pixel Film Studios. 2Health News:CannabisClassifieds.com Maintains its “Craigslist for Cannabis” Standing with Website Re-launch 2Health News:Concept Plus, LLC. Named One of Washington Technology’s Fast 50 2Health News:Eco-friendy Bamboo Flooring Manufacturer BambooIndustry.com Introduces Its Bamboo Flooring Promotion for 2015 2
... replacement complication rates, longer hospital stays for obese patientsLAS ... obesity is rising at alarming speeds across the United ... be putting their long-term musculoskeletal function in jeopardy, according ... of the American Academy of Orthopaedic Surgeons ...
... many children at risk for foot deformity due to wrong ... wearing shoes that are too small, according to a new ... American Academy of Orthopaedic Surgeons ( http://www.aaos.org/ ) ... risk for developing serious foot deformities.The study, which took place ...
... referred for psychiatric services following an emergency room visit ... they call for help, compared to about 20 percent ... 10 percent of all calls to mental health clinics ... within two weeks, according to a new University of ...
... available in French . , The countries ... to build research capacity and conduct clinical trials under best ... for the conduct of clinical trials) is the first EDCTP-funded ... high-quality clinical trials. It will be supported by a EUR ...
... root causes of defects on the production , lineOTTAWA, ... quality systems are used by companies around the world ... has been named a preferred supplier to one of ... in a key growth market for the company. , ...
... Smith & Nephew,s,Orthopaedics business and BrainLAB today ... exclusive vendor for developing and supporting,computer-assisted surgical technologies ... implants. , Starting in ... Smith & Nephew portfolio of instruments, implants and ...
Cached Medicine News:Health News:Obesity: A Musculoskeletal Nightmare 2Health News:Obesity: A Musculoskeletal Nightmare 3Health News:Obesity: A Musculoskeletal Nightmare 4Health News:If the Shoe Fits...or Does It? 2Health News:If the Shoe Fits...or Does It? 3Health News:For psychiatric services, wait for the beep 2Health News:For psychiatric services, wait for the beep 3Health News:CANTAM first African Network of Excellence for clinical trials 2Health News:Sciemetric makes the grade with major medical device manufacturer 2Health News:Smith & Nephew Orthopaedics and BrainLAB Announce Exclusive Computer-Assisted Surgery Development Agreement 2Health News:Smith & Nephew Orthopaedics and BrainLAB Announce Exclusive Computer-Assisted Surgery Development Agreement 3Health News:Smith & Nephew Orthopaedics and BrainLAB Announce Exclusive Computer-Assisted Surgery Development Agreement 4
The ISI Digi Grip has the strength needed for secure ,upper extremity traction....
The ApexPro CH is operational within the WMTS. It offers operating performance, up to 240 WMTS channels, and up to 120 hours of battery life....
... portable TeleMon companion monitor, and IntelliVue ... and monitoring solution for ambulating patients ... and SpO2. Clinicians can get access ... from the central station, monitoring cockpit, ...
ISI DuraHand is the reusable, easy to sterilize surgical hand immobilizer....
Medicine Products: